AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

LEVOSULPIRIDE

22 registrations across 7 African markets— 20 active

Markets with LEVOSULPIRIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DISLEP​ ​TABLETS🇬🇭GhanaactiveMay 2030
DISLEP​ ​TABLETS🇬🇭GhanaactiveMay 2030
MICROPRIDE-25
TABLET
🇷🇼RwandaMicro Labs LimitedactiveAug 2029
DISLEP 25MG
TABLET
🇷🇼RwandaDOPPEL FARMACEUTICI S.R.L.,activeJul 2029
DISLEP 25MG/2ML SOLUTION INJECTABLE BOITE DE 6🇨🇮Côte d'IvoireFERRER INTERNACIONALS.AactiveJun 2027
DISLEP 25MG COMPRIME BOITE DE 20🇨🇮Côte d'IvoireFERRER INTERNACIONALS.AactiveJun 2027
LEVOPIRID-GH 25MG COMPRIME BOITE DE 20🇨🇮Côte d'IvoireGENERIC HEALTHCARE PVT. LTDexpiredJan 2023
LEVOPIRID-GH 25MG/2,5ML SOLUTION INJECTABLE EN AMPOULE BOITE DE 6🇨🇮Côte d'IvoireGENERIC HEALTHCARE PVT. LTDexpiredJan 2021
DISLEP
ampoule injectable / 25 mg
🇸🇳SenegalFERRER INTERNATIONAL S.A.active
LEVOSULPIRIDE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaFERRER INTERNATIONAL, S.A.active
LEVOSULPIRIDE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaFERRER INTERNATIONAL, S.A.active
LEOS
comprimé / 25 mg
🇸🇳SenegalNEXUS PHARMA LTDactive
LEVOPIRID-GH
comprime / 25 mg
🇸🇳SenegalGENERIC HEALTHCARE PVT.LTDactive
Dislep 25
Tablets
🇹🇿TanzaniaFerrer Internacional, S.A.active
DISLEP
comprimé / 25 mg
🇸🇳SenegalFERRER INTERNATIONAL S.A.active
DISLEP® 25 CP BTE(1 X 20) FERRER INTERNACIONAL
Comprimé, Boîte de 1 blister
🇲🇬MadagascarFERRER INTERNACIONAL, S.A.active
LEVOPIRID
injectable / 25 mg
🇸🇳SenegalGENERIC HEALTHCARE PVT LTDactive
MICROPRIDE-25 CP BTE(3 X 10) MICRO LABS
Comprimé, Boîte de 3 blisters
🇲🇬MadagascarMICRO LABS LTD (No. 31)active
DISLEP® 25 CP BTE(1 X 20) FERRER INTERNACIONAL
Comprimé, Boîte de 1 blister
🇲🇬MadagascarFERRER INTERNACIONAL, S.A.active
LEVOSULPIRIDE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaFERRER INTERNATIONAL, S.A.active
LEVOSULPIRIDE
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaFERRER INTERNATIONAL, S.A.active
MICROPRIDE-25 CP BTE(3 X 10) MICRO LABS
Comprimé, Boîte de 3 blisters
🇲🇬MadagascarMICRO LABS LTD (No. 31)active

LEVOSULPIRIDE in Africa — Regulatory Overview

LEVOSULPIRIDE is registered across 7 African markets with 22 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Uganda, Madagascar, Côte d'Ivoire and 3 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 22 registrations, 20 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.